A modified lipid composition in Fabry disease leads to an intracellular block of the detergent-resistant membrane-associated dipeptidyl peptidase IV

J Inherit Metab Dis. 2010 Aug;33(4):445-9. doi: 10.1007/s10545-010-9114-6. Epub 2010 May 22.

Abstract

Fabry disease is an X-linked lysosomal storage disorder that leads to abnormal accumulation of glycosphingolipids due to a deficiency of alpha-galactosidase A (AGAL). The consequences of these alterations on the targeting of membrane proteins are poorly understood. Glycosphingolipids are enriched in Triton-X-100- resistant lipid rafts [detergent-resistant membranes (DRMs)] and play an important role in the transport of several membrane-associated proteins. Here, we show that In fibroblasts of patients suffering from Fabry disease, the colocalization of AGAL with the lysosomal marker LAMP2 is decreased compared with wild-type fibroblasts concomitant with a reduced transport of AGAL to lysosomes. Furthermore, overall composition of membrane lipids in the patients' fibroblasts as well as in DRMs reveals a substantial increase in the concentration of glycolipids and a slight reduction of phosphatidylethanolamine (PE). The altered glycolipid composition in Fabry fibroblasts is associated with an intracellular accumulation and impaired trafficking of the Triton-X-100 DRM-associated membrane glycoprotein dipeptidyl peptidase IV (DPPIV) in transfected Fabry cells, whereas no effect could be observed on the targeting of aminopeptidase N (ApN) that is not associated with this type of DRM. We propose that changes in the lipid composition of cell membranes in Fabry disease disturb the ordered Triton X-100 DRMs and have implications on the trafficking and sorting of DRM-associated proteins and the overall protein-lipid interaction at the cell membrane. Possible consequences could be altered signalling at the cell surface triggered by DRM-associated proteins, with implications on gene regulation and subsequent protein expression.

MeSH terms

  • Cell Culture Techniques
  • Detergents / pharmacology*
  • Dipeptidyl Peptidase 4 / genetics
  • Dipeptidyl Peptidase 4 / metabolism*
  • Fabry Disease / genetics
  • Fabry Disease / metabolism*
  • Fibroblasts / cytology
  • Fibroblasts / metabolism
  • Golgi Apparatus / metabolism
  • Humans
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / enzymology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Octoxynol / pharmacology*
  • Phosphatidylcholines / metabolism
  • Phosphatidylethanolamines / metabolism
  • Protein Transport / physiology
  • Sphingolipids / metabolism
  • alpha-Galactosidase / genetics

Substances

  • Detergents
  • Membrane Proteins
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Sphingolipids
  • Octoxynol
  • alpha-Galactosidase
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4